Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660146) titled 'Validity of Ashley Howe's Analysis for the Prediction of the Extraction Treatment Decision ... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661498) titled 'Indomethacin for Biliary ERCP Patients' on June 11. Brief Summary: This study is a randomi... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660822) titled 'THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS' on June 16. Brief Summary: Studies comparing ... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More
Singapore, June 23 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More